Here’s Otsuka’s digital health strategy around mental health
Otsuka's top U.S.-based leaders spoke about the company's partnerships in mental health and how it is driving innovation in big pharma.
Beyond the pill trend marks milestone with Proteus-Otsuka digital medicine-NDA application
Proteus Digital Health paired its ingestible sensor platform with Otsuka Pharmaceuticals' FDA-approved Abilify drug to treat people with schizophrenia and other serious mental health problems to monitor adherence.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.